USE OF AGOMELATINE IN OBTAINING MEDICAMENTS INTENDED FOR THE TREATMENT OF OBSESSIVE-COMPULSIVE DISORDER (OCD)

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20120309838A1
SERIAL NO

13578383

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the use of agomelatine, or N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide, in obtaining medicaments intended for the treatment of Obsessive-Compulsive Disorder (OCD).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
LES LABORATOIRES SERVIERFRANCE FAVERGES HAUTE-SAVOIE

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Laigle, Laurence Maisons Laffitte, FR 1 0
Millan, Mark Le Pecq, FR 58 364
Mocaer, Elisabeth Neuily Sur Seine, FR 7 11

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation